PROMETHEUS BIOSCIENCES INC (RXDX)       108.68  +0.25 (+0.23%)

108.68  +0.25 (+0.23%)

US74349U1088 - Common Stock - After market: 108.68 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 149.11. This target is 37.2% above the current price.
RXDX was analyzed by 17 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about RXDX.
In the previous month the buy percentage consensus was at a similar level.
RXDX was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 108.68115.14144.84149.11194.25 - 5.94% 33.27% 37.20% 78.74%

Up and Down Grades

Date Firm Action Rating
2023-01-31 Goldman Sachs Maintains Buy
2022-12-08 BTIG Maintains Buy
2022-12-08 Oppenheimer Maintains Outperform
2022-12-08 RBC Capital Maintains Outperform
2022-12-08 Credit Suisse Maintains Outperform
2022-11-01 Stifel Maintains Buy
2022-10-04 Oppenheimer Maintains Outperform
2022-10-04 RBC Capital Maintains Outperform
2022-10-03 BTIG Maintains Buy
2022-08-29 Wells Fargo Maintains Overweight
2022-08-29 Piper Sandler Maintains Overweight
2022-08-12 SVB Leerink Maintains Outperform
2022-08-12 Credit Suisse Maintains Outperform
2022-07-20 Goldman Sachs Initiate Buy
2022-06-10 Piper Sandler Initiate Overweight
2022-05-13 RBC Capital Maintains Outperform
2022-05-13 Wells Fargo Maintains Overweight
2022-03-10 SVB Leerink Maintains Outperform
2022-03-10 Wells Fargo Maintains Overweight
2022-03-10 Credit Suisse Maintains Outperform
2022-02-11 BTIG Initiate Buy
2021-12-13 RBC Capital Initiate Outperform
2021-12-08 Oppenheimer Upgrade Perform -> Outperform
2021-12-08 SVB Leerink Maintains Outperform
2021-12-08 Wells Fargo Initiate Overweight
2021-11-15 Oppenheimer Downgrade Outperform -> Perform
2021-11-15 SVB Leerink Maintains Outperform
2021-10-05 Oppenheimer Initiate Outperform
2021-04-06 Guggenheim Initiate Buy
2021-04-06 SVB Leerink Initiate Outperform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA